[1]张小力,刘 芹,刘宝瑞.重楼皂苷抗肿瘤及调节肿瘤免疫微环境研究进展[J].陕西中医,2021,(11):1640-1643.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.033]
　ZHANG Xiaoli,LIU Qin,LIU Baorui.Advances in anti-tumor effects of paris saponins[J].,2021,(11):1640-1643.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.033]
点击复制

重楼皂苷抗肿瘤及调节肿瘤免疫微环境研究进展
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2021年11期
页码:
1640-1643
栏目:
综 述
出版日期:
2021-11-05

文章信息/Info

Title:
Advances in anti-tumor effects of paris saponins
作者:
张小力1; 刘 芹2; 刘宝瑞1; 2
(1.南京中医药大学中西医结合鼓楼临床医学院,江苏 南京 210008; 2.南京大学医学院附属鼓楼医院,江苏 南京 210008)
Author(s):
ZHANG Xiaoli; LIU Qin; LIU Baorui
(Clinical College of Integrated Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Nanjing 210008,China)
关键词:
肿瘤;  重楼皂苷;  免疫调节;  肿瘤微环境;  癌毒理论;  抗肿瘤血管生成
Keywords:
Tumor;  Pariphyllin;  Immunomodulatory;  Tumor microenvironment;  Cancer toxin theory;  Anti-tumor angiogenesis
分类号:
R 73
DOI:
DOI:10.3969/j.issn.1000-7369.2020.11.033
文献标志码:
A
摘要:
重楼是清热解毒的传统中药,临床广泛运用于抗肿瘤、抗菌、止血等领域,重楼皂苷是重楼最主要的抗肿瘤活性成分。目前重楼皂苷的抗肿瘤效果缺乏系统总结,现从中医对肿瘤病因病机认识入手,综合重楼皂苷抗肿瘤作用机制的现代医学研究,阐述了重楼皂苷通过内质网应激、线粒体途径诱导肿瘤细胞凋亡和细胞周期阻滞起到直接抗肿瘤作用。此外,进一步归纳重楼皂苷在调节肿瘤免疫微环境等方面发挥抗肿瘤和免疫调节功能的机制,包括提高免疫细胞反应性、调节细胞因子和肿瘤血管生成相关黏附分子的表达以及抑制细胞外基质降解等,从中医角度对肿瘤微环境抑制机制进行解读,以期为该中药单体的基础研究和临床应用提供更多参考。
Abstract:
Paris polyphylla is a kind of heat clearing and detoxifying medicine and this kind of traditional Chinese medicine is widely used in anti-cancer,anti-bacterial,hemostasis and other fields.Polyphyllins are the main anti-tumor active components of Paris polyphylla.At present,the anti-tumor effect of polyphyllins is lack of systematic summary.This article starts with the understanding of tumor etiology and pathogenesis in traditional Chinese medicine,and integrates the modern medical research on the anti-tumor mechanism of polyphyllins.It expounds that polyphyllin plays a direct anti-tumor role through endoplasmic reticulum stress,apoptosis induced by mitochondrial pathway and cell cycle arrest.In addition,the mechanism of polyphyllin in regulating tumor immune microenvironment was further summarized,including improving immune cell reactivity,regulating the expression of cytokines and tumor angiogenesis related adhesion molecules,and inhibiting the degradation of extracellular matrix.The inhibition mechanism of tumor microenvironment was interpreted from the perspective of traditional Chinese medicine,in order to provide more reference for the basic research and clinical application of the traditional Chinese medicine monomer.

参考文献/References:

[1] 国家药典委员会.中华人民共和国药典[M].北京:中国医药科技出版社,2015:248.
[2] 钟月姣,刘 莹,于新海,等.重楼活性成分及药理作用的研究进展[J].黑龙江畜牧兽医,2016,59(2):69-71.
[3] 侯 梅,陈贺骏涛,苏婧婧,等.重楼皂苷Ⅱ诱导人胃癌MGC-803细胞凋亡的体外研究[J].中南药学,2019,17(5):647-651.
[4] 张 欣,王 菲,许 欢,等.灯台七总皂苷提取工艺优化及其抗肿瘤活性研究[J].陕西中医,2017,38(9):1294-1297.
[5] Feldman DE,Chauhan V,Koong AC.The unfolded protein response:A novel component of the hypoxic stress response in tumors[J].Molecular Cancer Research,2005,3(11):597-605.
[6] 张嘉玲,郑长军,杨瑞琦,等.重楼皂苷通过内质网应激抑制荷瘤小鼠移植瘤生长[J].中国实验诊断学,2015,27(9):1450-1453.
[7] Nakagawa T,Zhu H,Morishima N,et al.Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta[J].Nature,2000(403):98-103.
[8] 阳丹丹,齐 琪,陈正礼,等.内质网应激调控重楼皂苷Ⅰ诱导肝癌HepG2细胞凋亡的研究[J].中国细胞生物学学报,2017,22(11):1397-1406.
[9] Arap MA,Lahdenranta J,Mintz PJ,et al.Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands[J].Cancer Cell,2004,6(3):275-284.
[10] Denoyelle C,Abourjaily G,Bezrookove V,et al.Anti-oncogenic role of the endoplasmic reticulum differentially activated by mutations in the MAPK pathway[J].Nature Cell Biology,2006,8(10):1053-1063.
[11] Jacobson MD,Burne JF,King MP,et al.Bcl-2 blocks apoptosis in cells lacking mitochondrial DNA[J].Nature,1993(361):365-369.
[12] 朱炎杰,高维娟.Cyt-C与Caspase在细胞凋亡中的作用及相互关系[J].中国老年学杂志,2011,31(15):2990-2992.
[13] Czabotar PE,Lessene G,Strasser A,et al.Control of apoptosis by the Bcl-2 protein family:Implications for physiology and therapy[J].Nature Reviews Molecular Cell Biology,2014,15(1):49-63.
[14] 陈舒怡,沈自尹,黄建华,等.重楼皂苷Ⅰ通过线粒体碎裂诱导人肺癌NCI-H661细胞凋亡[J].中华中医药杂志,2018,33(2):538-541.
[15] Zeng YW,Zhang ZQ,Wang WP,et al.Underlying mechanisms of apoptosis in HepG2 cells induced by polyphyllin I through fas death and mitochondrial pathways[J].Toxicology Mechanisms and Methods,2020(1):1-26.
[16] Zhou HP,Sun Y,Zheng HN,et al.Paris saponin VII extracted from trillium tschonoskii suppresses proliferation and induces apoptosis of human colorectal cancer cells[J].Journal of Ethnopharmacology,2019(239):111903.
[17] 李玲珺,李 霞.基于微管靶点的抗肿瘤药物研究进展[J].中国药师,2017,20(1):139-143.
[18] 于 思,曹治兴,杨雨婷,等.重楼皂苷Ⅰ诱导G2/M期阻滞及干扰微管结构抗结肠癌HCT116细胞作用机制[J].中国实验方剂学杂志,2017,23(6):149-154.
[19] Zhang DL,Liu S,Liu ZY,et al.Polyphyllin I induces cell cycle arrest in prostate cancer cells via the upregulation of IL-6 and P21 expression[J].Medicine,2019,98(44):17743.
[20] Li JL,Ma WL,Cheng XM,et al.Activation of FOXO3 pathway is involved in polyphyllin I-induced apoptosis and cell cycle arrest in human bladder cancer cells[J].Archives of Biochemistry and Biophysics,2020(687):108363.
[21] 周晴晴,李慧杰,李秀荣.基于癌毒理论探讨攻毒治法抗肿瘤血管生成[J].陕西中医,2020,41(8):1134-1138.
[22] 王 娟,刘瑞洪,肖红波,等.重楼皂甙Ⅱ对狼疮性肾炎患者外周血CD4+与CD25+T调节细胞表达的细胞因子的影响[J].现代生物医学进展,2010,10(1):50-53.
[23] 李春江.重楼皂苷抗乳腺癌及免疫调节作用研究[D].长春:东北师范大学,2011.
[24] Hanahan D,Weinberg RA.Hallmarks of cancer:The next generation[J].Cell,2011,144(5):646-674.
[25] 朱 燕.重楼醇提物联合奥沙利铂及CIK细胞、趋化因子CXCL10对人结肠癌细胞SW480的作用及机制探讨[D].南京:南京中医药大学,2015.
[26] 侯 敏,王凯国.Th1/Th2偏移与胃癌关系的研究进展[J].山东医药,2016,19(1):96-98.
[27] 柴红妍.重楼皂苷抗肿瘤肺转移机制研究[D].天津:天津科技大学,2016.
[28] 滕文静,周 超,曹晓靖,等.重楼皂苷影响JAK/STAT3通路诱导结直肠癌细胞凋亡[J].时珍国医国药,2015,26(4):808-811.
[29] 胡 静,钱晓萍,刘宝瑞,等.重楼醇提物抗鼠H22移植瘤血管生成的体内实验研究[J].现代肿瘤医学,2010,18(10):1886-1889.
[30] 邓碧凡,廖 敏,邱荣敏,等.重楼皂苷Ⅰ对低氧喉癌Hep-2细胞增殖和HIF-1α、VEGF表达的影响[J].安徽医科大学学报,2016,51(11):1613-1617.
[31] Lee WS,Yang HN,Chon HJ,et al.Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity[J].Exp Mol Med,2020,52(9):1475-1485.
[32] 吕 芸,李晓玲.重楼皂苷D抑制A549细胞转移作用及机制研究[J].中国药业,2015,24(22):35-36.
[33] 李宇华,孙 阳,樊 磊,等.重楼皂苷Ⅵ抑制结肠癌LoVo细胞转移的作用及机制研究[J].华南国防医学杂志,2015,29(8):571-574.
[34] 韩 策,尤向辉,聂 娜,等.肿瘤免疫治疗研究进展[J].陕西医学杂志,2015,36(4):502-503.
[35] Chang HL,Kuo YH,Wu LH,et al.The extracts of overcome tumor immune tolerance by inhibition of tumor programmed cell death protein ligand-1 expression[J].Int J Med Sci,2020,17(7):939-945.
[36] 雷 秦,王梦昌,王 娟.苦参碱对NK细胞杀伤HL60细胞的影响及其机制研究[J].陕西医学杂志,2015,44(10):1275-1277.
[37] Mo LJ,Zhang XJ,Shi XJ,et al.Norcantharidin enhances antitumor immunity of GM-CSF prostate cancer cells vaccine by inducing apoptosis of regulatory T cells[J].Cancer Science,2018,109(7):2109-2118.

相似文献/References:

[1]黄越秀,陈光伟,张家墉△,等.陈光伟教授治疗肿瘤根治术后肠麻痹经验[J].陕西中医,2020,(11):1654.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.036]
[2]曾普华.从炎性微环境探析肿瘤恶液质的“癌毒致虚”病机观[J].陕西中医,2021,(8):987.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.001]
　ZENG Puhua.Analysis of the “cancer toxin-induced deficiency” pathogenesis of tumor cachexia from the inflammatory microenvironment[J].,2021,(11):987.[doi:DOI:10.3969/j.issn.1000-7369.2020.08.001]
[3]王中会,晁 旭,吕天依,等.土贝母苷甲抗肿瘤作用机制研究进展[J].陕西中医,2021,(11):1652.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.036]
　WANG Zhonghui,CHAO Xu,LYU Tianyi,et al.Research progress on the Anti-solid tumor mechanism of TBMSⅠ[J].,2021,(11):1652.[doi:DOI:10.3969/j.issn.1000-7369.2020.11.036]
[4]张美英,张 英,侯 炜.基于数据挖掘探讨黄芪抗肿瘤复方的临床应用[J].陕西中医,2023,(7):957.[doi:DOI:10.3969/j.issn.1000-7369.2023.07.031]
[5]冯薪宇,罗富锟,胡利来,等.肿瘤中医病机发展与“辨病识机”指导意义[J].陕西中医,2025,46(2):237.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.019]
　FENG Xinyu,LUO Fukun,HU Lilai,et al.The innovative development of TCM tumor pathogenesis and the guiding significance of “disease identification machine”[J].,2025,46(11):237.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.019]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(81972309)
更新日期/Last Update: 2021-11-10